A detailed history of Glen Eagle Advisors, LLC transactions in Illumina, Inc. stock. As of the latest transaction made, Glen Eagle Advisors, LLC holds 39 shares of ILMN stock, worth $5,758. This represents 0.0% of its overall portfolio holdings.

Number of Shares
39
Previous 76 48.68%
Holding current value
$5,758
Previous $18 Million 77.34%
% of portfolio
0.0%
Previous 0.01%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$101.05 - $133.57 $3,738 - $4,942
-37 Reduced 48.68%
39 $4.07 Million
Q1 2024

Jul 03, 2024

BUY
$127.73 - $147.2 $4,981 - $5,740
39 New
39 $5.36 Million
Q4 2023

Aug 13, 2024

SELL
$92.79 - $142.53 $1,206 - $1,852
-13 Reduced 25.0%
39 $5.43 Million
Q1 2023

Aug 13, 2024

BUY
$193.75 - $232.55 $775 - $930
4 Added 8.33%
52 $12.1 Million
Q3 2022

Aug 13, 2024

BUY
$177.23 - $227.44 $1,595 - $2,046
9 Added 23.08%
48 $9.16 Million
Q3 2020

Aug 13, 2024

SELL
$268.51 - $400.74 $268 - $400
-1 Reduced 2.5%
39 $12.1 Million
Q3 2019

Aug 13, 2024

SELL
$266.84 - $378.23 $17,878 - $25,341
-67 Reduced 62.62%
40 $12.2 Million
Q2 2019

Aug 13, 2024

BUY
$300.59 - $368.15 $300 - $368
1 Added 0.94%
107 $39.4 Million
Q1 2019

Aug 13, 2024

BUY
$272.57 - $321.18 $18,262 - $21,519
67 Added 171.79%
106 $32.9 Million
Q3 2018

Aug 13, 2024

BUY
$279.04 - $367.06 $8,371 - $11,011
30 Added 39.47%
106 $38.9 Million
Q2 2018

Aug 13, 2024

SELL
$228.17 - $292.07 $2.09 Million - $2.68 Million
-9,181 Reduced 99.18%
76 $21.2 Million
Q1 2018

Aug 14, 2024

BUY
$209.54 - $253.91 $7,752 - $9,394
37 Added 94.87%
76 $18 Million
Q1 2018

Aug 13, 2024

BUY
$209.54 - $253.91 $1.92 Million - $2.33 Million
9,181 Added 12080.26%
9,257 $18 Million
Q3 2017

Aug 13, 2024

BUY
$172.3 - $213.93 $6,375 - $7,915
37 Added 94.87%
76 $15.1 Million
Q4 2016

Aug 12, 2024

BUY
N/A
37
76 $9.73 Million

Others Institutions Holding ILMN

About ILLUMINA, INC.


  • Ticker ILMN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 157,300,000
  • Market Cap $23.2B
  • Description
  • Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....
More about ILMN
Track This Portfolio

Track Glen Eagle Advisors, LLC Portfolio

Follow Glen Eagle Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Glen Eagle Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Glen Eagle Advisors, LLC with notifications on news.